Rare Disease Report
Physicians
Physicians
Patients & Caregivers

About

Rare Disease Report is a website and weekly e-newsletter that offers an independent voice for the Rare Disease Community. It strives to bring together medical, scientific, investment, regulatory, and advocate professionals interested in rare diseases and orphan drugs.

Our Advisory Board includes:

Peter C. Adamson, MD
Chair, Children's Oncology Group
Chief, Division of Clinical Pharmacology & Therapeutics
The Children's Hospital of Philadelphia
 
Christie Ballantyne, MD
Professor, Molecular and Human Genetics, Baylor College of Medicine
 
Nicole Boice
Founder & CEO, Global Genes
 
Kyle Brown
CEO and founder of PatientCrossroads
 
Lucie Bruijn, PhD
Science Director at Amyotrophic Lateral Sclerosis Association
 
Barbara K Burton, MD
Director, PKU Program; Professor of Pediatrics,
Northwestern University Feinberg School of Medicine
 
Mark Cannon, DDS
Professor, Clinical Otolarynology Dental Surgery
 
Shan Chandrakasan, MD
Cincinnati Children’s Medical Center
 
Joshua P. Cohen, PhD
Senior Research Fellow/ Research Assistant Professor.
Tufts Center for the Study of Drug Development
 
Timothy Craig, DO 
Allergy, Immunology and Respiratory Diseases, Penn State Hershey Medicine
 
Lawrence A. Frohman, MD
Professor Emeritus of Medicine, Division of Endocrinology,
Metabolism, and Diabetes, University of Illinois at Chicago
 
Pat Furlong 
Founder and CEO of Parents Project MD
 
William Gannon Jr, MD
Chief Scientific Officer & Medical Director,
Capital City Technical Consulting
 
Guillermo Garcia-Manero, MD
Professor, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center
 
Audrey Gordon
President, Progeria Research Foundation
 
Eric Hoffman, PhD
ReveraGen Biopharma; Vice President, AGADA Biosciences; Director, Center for Genetic Medicine Research, Children's National Medical Center; Professor and Chair, Department of Integrative Systems Biology, George Washington University
 
Melissa Hogan
Founder, Saving Case
 
Jeffrey Jones, MD
Assistant Professor of Internal Medicine, Ohio State University
 
Wahida Karmally, DrPH, RD, CDE, CLS, FNLA
Irving Institute for Clinical and Translational Research, Columbia University
 
Thomas Kirkegaard Jensen, PhD
Chief Scientific Officer, Orphazyme ApS
 
Abhishek Kumar, MD
Hematology Oncology, New York Medical College-St. Joseph’s Regional Medical Center
 
Michael Levy, MD, PhD 
Assistant Professor, Johns Hopkins University
Medical Director of General Neurology, Johns Hopkins Hospital
 
Phillip A Low, MD
Professor of Neurology, Mayo Clinic
 
Kari Luther Rosbeck
President & Chief Executive Officer, Tuberous Sclerosis Alliance

Pam Mace, RN
FMD Patient and Executive Director, Fibromuscular Dysplasia Society of America
 
Brian Malkin 
McGuireWoods LLP; Co-editor www.fdalife.com
 
Jay (John T.) Matthews, MBA, PhD
Associate Director
Global Clinical Trial Operations, The Americas | Merck Research Laboratories
 
John Mascarenhas, MD
Associate Professor, Medicine, Hematology and Medical Oncology, Mount Sinai Hospital
 
Nikhil Munshi, MD
Professor of Medicine, Harvard Medical School
 
Brian P. O'Sullivan, MD
Professor of Pediatrics;  Director, Cystic Fibrosis Center; Chair,
Institutional Review Board; Associate Vice-Provost for Research, UMass Medical School
 
Shin Oh, MD
Neurologist, University of Alabama Birmingham
 
Marlana Orloff, MD
Oncologist, Thomas Jefferson University
 
Amy Paller, MD
Chair of Dermatology, Professor of Pediatrics, Northwestern University Feinberg School of Medicine
 
Ethan Perstein, PhD
Founder and CEO, Perlstein Lab
 
Javier M Romero, MD
Director of Ultrasound, Associate Director of Neurovascular Laboratory, Massachusetts General Hospital
 
H Diana Rosas, MD
Associate Professor Neurology, Harvard Medical School; Neurologist, Massachusetts General Hospital;
Director, Center for Neuro-imaging of Aging and Neurodegenerative Disease.
 
Yaffa Rubinstein, PhD
Director of Patient Resources for Clinical and Translational Research,
Office of Rare Diseases Research (ORDR), National Center for Advancing Translational Sciences (NCATS). National Institutes of Health
 
Phillip W Ruff PhD, CChem, MRSC
Director, Global Market Access, Shire
 
Scott Shirley
Executive Director, Uplifting Athletes
 
Dean Suhr
President and Co-founder, MLD Foundation; Registry Manager, Genetic Alliance; rare disease advocate and consultant
 
Jitske Tiemensma
Assistant Professor, University of California, Merced
 
Shunji Tomatsu MD, PhD
Director, Skeletal Dysplasia Lab,  Departments of Biomedical Research and Orthopedics, 
ARB 331 Nemours/Alfred I. duPont Hospital for Children
 
Clara van Karnebeek MD, PhD, FCCMG
Assistant Professor Biochemical Genetics & Pediatrics, University of British Columbia, Vancouver Canada
 
Louise Vetter
CEO of Huntington’s Disease Society of America.
 
James Underberg, MD
Director, Bellevue Hospital Primary Care Lipid Management Clinic, NYC
 
Neal J Weinreb, MD, FACP
Voluntary Associate Professor of Medicine, Dr John A Macdonald Foundation Department of Human Genetics, University of Miami Miller School of Medicine.
Director, University Research Foundation for Lysosomal Storage Diseases Inc, Coral Springs and Boca Raton, Florida, USA
 
James Wheless, MD
Professor and Chief, Department of Pediatric Neurology, University of Tennessee Health Science Center
 
Don Wilson, MD
Physician of Pediatric Endocrinology, Cooks Children's Physician Network

 

Copyright © RareDR 2013-2017 Intellisphere, LLC. All Rights Reserved.